TransMedics Group, Inc. (TMDX) Free cash flow 2018–2025
TransMedics Group, Inc. (TMDX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$133.6MFY2025 · since FY2018: -$26.4M → $133.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $133.6M | +265.0% |
| FY2024 | -$80.9M | +50.9% |
| FY2023 | -$164.9M | -185.6% |
| FY2022 | -$57.7M | -78.3% |
| FY2021 | -$32.4M | -5.4% |
| FY2020 | -$30.7M | +5.3% |
| FY2019 | -$32.5M | -22.9% |
| FY2018 | -$26.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice